Table 5.

MAR for each risk criterion for 1% incremental benefit level, separated by perspective

	MAR level (%) for 1% incremental benefit level
Perspective	Myalgia (%)		Hepatotoxicity (%)
	Stroke	MI	Stroke	MI
Patients (N=223)	0.633	0.502	0.084	0.067
Clinical experts (N=63)	0.808	0.608	0.135	0.102
Policymakers (N=67)	1.123	0.965	0.134	0.115

MAR, maximum acceptable risk; MI, myocardial infarction.